We studied the following three groups (n=6 each): DS on a low (0.3% NaCl) salt diet (LS);DS on a high salt (8% NaCl) diet for 7 weeks (HS);and DS on a high salt diet for 7 weeks, followed by a single 3E9 monoclonal anti-MBG antibody treatment for 5 days (HSAB). Levels of MBG and levels of proteins implicated in pro-fibrotic signaling, and mRNA expression (paired analysis of gene expression, microarray analysis, Qiagen) in left ventricles (LV) and aortae were assessed. In HS vs. LS, BP increased by 74 mmHg (p <0.01), plasma MBG doubled (p <0.05), renal MBG excretion increased 6-fold (p <0.01), tissue weights increased (LV: 2.37 +/- 0.05 vs. 1.62 +/- 0.04 g/kg BW, p <0.01;aorta: 4.44 +/- 0.17 vs. 3.01 +/- 0.06 mg/mm*kg BW, p <0.01), and LV collagen rose 3.5-fold. A single intra-peritoneal administration of anti-MBG monoclonal antibody to hypertensive DS (HSAB group) reduces BP by 35 mmHg (p <0.01) after 5 days, and markedly reduces collagen-1 and weights of left ventricles and aortae (p<0.01) vs. HS group. In hypertensive DS there was a tissue-specific pattern of up-regulation of expression of genes, implicated in TGF-signaling (LV: TGFb1, TGFb2, MAPK3, CTGF, SMADs, collagen-1 (Table 1);aorta: TGFb2, TGFb3, PDGF, fibronectin, SNAIL1, PCOLCE, collagens;Table 2), that was down-regulated following immunoneutralization of MBG. These observations were supported by western blot and qPCR analyses. Thus, immunoneutralization of MBG in DS produces an anti-remodeling effect associated with down-regulation of genes implicated in TGF-induced fibrosis initiated by MBG in salt-sensitive hypertension. ================================================================= Table 1. Paired analysis of gene expression (Z-ratio) in LV of DS: Gene:___HS/LS vs. HSAB/HS:___Gene description: MAPK3___1.64 vs. -2.66___Mitogen activated protein kinase 3 TGFb1___1.72 vs. -2.20___Transforming growth factor beta 1 TGFb2___2.57 vs. -4.27___Transforming growth factor beta 2 CTGF___2.04 vs. -4.90___Connective tissue growth factor Col1a2___0.80 vs. -2.35___Collagen, type 1, alpha 2 ================================================================= Table 2. Paired analysis of gene expression (Z-ratio) in aorta of DS: Gene:___HS/LS vs. HSAB/HS:___Gene description TGFb2___2.46 vs. -1.60___Transforming growth factor beta 2 TGFb3___3.36 vs. -2.13___Transforming growth factor beta 3 PDGFa___1.08 vs. -1.00___Platelet-derived growth factor, alpha polypeptide PDGFra___2.58 vs. -2.43___Platelet-derived growth factor receptor, alpha polypeptide FN______4.75 vs. -4.14___Fibronectin ITG1b____2.14 vs. -2.16___Fibronectin receptor beta 1 SNAI1____2.29 vs. -4.98___Snail 1 homolog PCOLCE___2.55 vs. -2.74___Procollagen C-endopeptidase enhancer Col5a2___2.95 vs. -3.08___Collagen, type 5, alpha 2 Col11a1___1.75 vs. -5.74___Collagen, type 11, alpha 1 Col16a1___2.11 vs. -2.44___Collagen, type 16, alpha 1 Col17a1___1.76 vs. -1.10___Collagen, type 17, alpha 1 Col18a1___2.52 vs. -1.80___Collagen, type 18, alpha 1

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIAAG000609-20
Application #
8552423
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
2012
Total Cost
$581,580
Indirect Cost
Name
National Institute on Aging
Department
Type
DUNS #
City
State
Country
Zip Code
Strauss, Michél; Smith, Wayne; Wei, Wen et al. (2018) Marinobufagenin is related to elevated central and 24-h systolic blood pressures in young black women: the African-PREDICT Study. Hypertens Res 41:183-192
Chirinos, Julio A; Sardana, Mayank; Oldland, Garrett et al. (2018) Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure. ESC Heart Fail 5:911-919
Strauss, Michél; Smith, Wayne; Kruger, Ruan et al. (2018) Marinobufagenin and left ventricular mass in young adults: The African-PREDICT study. Eur J Prev Cardiol 25:1587-1595
Chirinos, Julio A; Sardana, Mayank; Syed, Amer Ahmed et al. (2018) Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension. J Am Soc Hypertens 12:681-689
AlGhatrif, Majd; Wang, Mingyi; Fedorova, Olga V et al. (2017) The Pressure of Aging. Med Clin North Am 101:81-101
Gable, Marjorie E; Ellis, Linda; Fedorova, Olga V et al. (2017) Comparison of Digitalis Sensitivities of Na(+)/K(+)-ATPases from Human and Pig Kidneys. ACS Omega 2:3610-3615
Fedorova, Olga V; Zernetkina, Valentina I; Shilova, Victoria Y et al. (2015) Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway. Circ Cardiovasc Genet 8:736-45
Fedorova, Olga V; Lakatta, Edward G; Bagrov, Alexei Y et al. (2015) Plasma level of the endogenous sodium pump ligand marinobufagenin is related to the salt-sensitivity in men. J Hypertens 33:534-41; discussion 541
Kennedy, David J; Shrestha, Kevin; Sheehey, Brendan et al. (2015) Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure. Circ Heart Fail 8:1068-76
Fedorova, Olga V; Emelianov, Igor V; Bagrov, Konstantin A et al. (2015) Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists. J Hypertens 33:1602-10

Showing the most recent 10 out of 23 publications